Literature DB >> 18185824

A roadmap to key pharmacologic principles in using antipsychotics.

.   

Abstract

Year:  2007        PMID： 18185824      PMCID： PMC2139919     

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  24 in total

Review 1.  Dopamine as a prolactin (PRL) inhibitor.

Authors:  N Ben-Jonathan; R Hnasko
Journal:  Endocr Rev       Date:  2001-12       Impact factor: 19.871

Review 2.  Classification of neuropsychiatric medications by principal mechanism of action: a meaningful way to anticipate pharmacodynamically mediated drug interactions (part II).

Authors:  Sheldon H Preskorn
Journal:  J Psychiatr Pract       Date:  2004-05       Impact factor: 1.325

Review 3.  Practice guideline for the treatment of patients with schizophrenia, second edition.

Authors:  Anthony F Lehman; Jeffrey A Lieberman; Lisa B Dixon; Thomas H McGlashan; Alexander L Miller; Diana O Perkins; Julie Kreyenbuhl
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

Review 4.  Modern antipsychotic drugs: a critical overview.

Authors:  David M Gardner; Ross J Baldessarini; Paul Waraich
Journal:  CMAJ       Date:  2005-06-21       Impact factor: 8.262

5.  Classification of neuropsychiatric medications by principal mechanism of action: a meaningful way to anticipate pharmacodynamically mediated drug interactions.

Authors:  Sheldon H Preskorn
Journal:  J Psychiatr Pract       Date:  2003-09       Impact factor: 1.325

Review 6.  Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.

Authors:  Douglas M Ziedonis; David Smelson; Richard N Rosenthal; Steven L Batki; Alan I Green; Renata J Henry; Ivan Montoya; Joseph Parks; Roger D Weiss
Journal:  J Psychiatr Pract       Date:  2005-09       Impact factor: 1.325

Review 7.  Pharmacology of antidepressants--characteristics of the ideal drug.

Authors:  E Richelson
Journal:  Mayo Clin Proc       Date:  1994-11       Impact factor: 7.616

8.  Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients.

Authors:  S Nyberg; L Farde; C Halldin
Journal:  Psychiatry Res       Date:  1996-10-07       Impact factor: 3.222

9.  Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications.

Authors:  W G Frankle; R Gil; E Hackett; O Mawlawi; Y Zea-Ponce; Z Zhu; L D Kochan; C Cangiano; M Slifstein; J M Gorman; M Laruelle; A Abi-Dargham
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

Review 10.  Translating the psychopharmacology of antipsychotics to individualized treatment for severe mental illness: a Roadmap.

Authors:  Peter J Weiden; Sheldon H Preskorn; Peter A Fahnestock; Daniel Carpenter; Ruth Ross; John P Docherty
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384
View more
  3 in total

Review 1.  Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies.

Authors:  Gianluca Trifiró; Janet Sultana; Edoardo Spina
Journal:  Drug Saf       Date:  2014-07       Impact factor: 5.606

2.  Patterns of Prescription of Psychotropic Medications and Their Adherence among Patients with Schizophrenia in Two Psychiatric Hospitals in Accra, Ghana: A Cross-Sectional Survey.

Authors:  Sharon Ashong; Irene A Kretchy; Barima Afrane; Ama de-Graft Aikins
Journal:  Psychiatry J       Date:  2018-01-01

Review 3.  Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: A systematic review.

Authors:  Eric Druyts; Michael J Zoratti; Kabirraaj Toor; Ping Wu; Salmaan Kanji; Kiran Rabheru; Edward J Mills; Kristian Thorlund
Journal:  BMC Pediatr       Date:  2016-11-09       Impact factor: 2.125
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.